Thursday, 12.9.2024
| 0830 - 0835 Kongresssaal | Opening of the SGG-SGVC-SASL-SVEP meeting 2024 Stephan Brand, St. Gallen |
| 0830 - 0835 Saal Grimsel | Opening of the SGG-SGVC-SASL-SVEP meeting 2024 Stephan Brand, St. Gallen |
| 0830 - 0835 Theatersaal | Opening of the SGG-SGVC-SASL-SVEP meeting 2024 Stephan Brand, St. Gallen |
| 0830 - 0835 Saal Brünig | Opening of the SGG-SGVC-SASL-SVEP meeting 2024 Stephan Brand, St. Gallen |
| 0830 - 0835 Saal Harder | Opening of the SGG-SGVC-SASL-SVEP meeting 2024 Stephan Brand, St. Gallen |
| 0830 - 0835 Auditorium | Opening of the SGG-SGVC-SASL-SVEP meeting 2024 (simultaneous interpreting into German and French) Stephan Brand, St. Gallen |
| 0835 - 1000 Auditorium | SVEP-SGG Session Jungfrau Marathon Endoscopy: What should a nurse and a physician know about these techniques? Part I: GI bleeding (simultaneous interpreting into German and French) Frank Bieger, Baden Lukas Degen, Basel Tobias Ehmann, Zofingen |
| 0835 - 0905 Auditorium | Upper non-variceal GI bleeding Alexander Meining, Würzburg, Germany |
| 0905 - 0930 Auditorium | Variceal bleeding Reiner Wiest, Bern |
| 0930 - 1000 Auditorium | Lower GI bleeding Jan Borovicka, St. Gallen |
| 0835 - 1000 Theatersaal | IBD treatment 2024 sponsored by MSD Stephan Brand, St. Gallen Pierre Michetti, Lausanne |
| 0835 - 0900 Theatersaal | IL-23: A new key player in the pathogenesis of IBD Stephan Brand, St. Gallen |
| 0900 - 0920 Theatersaal | Novel anti-IL-23 therapies in IBD Geert D'Haens, Amsterdam, The Netherlands |
| 0920 - 0940 Theatersaal | My patient's "PROFILE": How to personalize IBD therapy after the PROFILE study Nurulamin Noor, Cambridge, United Kingdom |
| 0940 - 1000 Theatersaal | Optimizing anti-TNF treatment in IBD Shomron Ben-Horin, Tel Aviv, Israel |
| 0835 - 1000 Kongresssaal | New Challenges in Hepatology David Semela, St. Gallen Andreas Kremer, Zürich |
| 0835 - 0900 Kongresssaal | Alcohol-related liver disease Ramon Bataller, Barcelona, Spain |
| 0900 - 0920 Kongresssaal | BAVENO VIII update Cristina Ripoll, Jena, Germany |
| 0920 - 0940 Kongresssaal | Combination therapy for HCC Peter R. Galle, Mainz, Germany |
| 0940 - 1000 Kongresssaal | Challenges in liver transplantation José Oberholzer, Zürich |
| 0835 - 1000 Saal Brünig | SGVC Session I: Update in diagnosis and treatment of GIST Ralph Peterli, Basel Markus Weber, Zürich |
| 0835 - 0845 Saal Brünig | Diagnosis of GIST: Pathologist Achim Weber, Zürich |
| 0845 - 0855 Saal Brünig | Diagnosis of GIST: Radiologist Irene Burger, Baden |
| 0855 - 0915 Saal Brünig | Endoscopic resection in localized disease Christoph Gubler, Zürich |
| 0915 - 0940 Saal Brünig | Surgery in localized disease Corina Kim-Fuchs, Bern |
| 0940 - 1000 Saal Brünig | Neoadjuvant, adjuvant and palliative systemic therapy Antonia Digklia, Lausanne |
| 1000 - 1030 Exhibition Area | Coffee break |
| 1030 - 1200 Auditorium | Joint session: The summits of Swiss research: Prize Winners in gastroenterology, hepatology, and surgery (simultaneous interpreting into German and French) Stephan Brand, St. Gallen Antonio Nocito, Baden David Semela, St. Gallen Alain Vonlaufen, Genève |
| 1100 - 1200 Auditorium | Keynote lecture by the Nobel Prize Laureate 2005 Barry Marshall: The discovery of H.-pylori as cause for gastroduodenal ulcer and gastritis |
| 1030 - 1200 Saal Harder | SVEP-ASPE: Meet the expert 2024: IBD (sponsored by Janssen-Cilag, Takeda Pharma) Frank Bieger, Baden Luc Biedermann, Zürich Dritë Rushiti, Chur Jan Hendrik Niess, Basel Elisabeth Winkler, Wien, Austria Barbara Dora, Zürich |
| 1030 - 1200 Saal Grimsel | SVEP-ASPE: Meet the expert 2024: IBD (sponsored by Janssen-Cilag, Takeda Pharma) Frank Bieger, Baden Luc Biedermann, Zürich Dritë Rushiti, Chur Jan Hendrik Niess, Basel Elisabeth Winkler, Wien, Austria Barbara Dora, Zürich |
| 1200 - 1330 Exhibition Area | Lunch Break |
| 1215 - 1245 Kongresssaal | Lunch Symposium Janssen-Cilag: Treatment Choices in IBD - Trust your Experience Luc Biedermann, Zürich Stephan R. Vavricka, Zürich |
| 1215 - 1245 Theatersaal | Lunch Symposium Gilead Switzerland: Bulevirtide: Transforming the Hepatitis D Treatment Andreas Kremer, Zürich Montserrat Fraga, Lausanne Nasser Semmo, Bern |
| 1250 - 1320 Theatersaal | Lunch Symposium Pfizer: The era of oral advanced therapies for the treatment of ulcerative colitis Alain Schoepfer, Lausanne Luc Biedermann, Zürich |
| 1250 - 1320 Kongresssaal | Lunch Symposium Olympus: Endoscopic Handsuturing: new chances – new challenges (Schlag) / New frontiers in EUS performance (Seewald) Christoph Schlag, Zürich Stefan Seewald, Zürich |
| 1300 - 1320 Saal Brünig | Special lecture: Measuring outcome in Surgery. Have we done all wrong? Pierre-Alain Clavien, Zürich |
| 1330 - 1500 Auditorium | SVEP-SGG Session Jungfrau Marathon Endoscopy: What should a nurse and a physician know about these techniques? Part II: Colorectal cancer screening (simultaneous interpreting into German and French) Jan Borovicka, St. Gallen Kaspar Truninger, Zürich Jean-Louis Frossard, Genève |
| 1330 - 1400 Auditorium | Colorectal cancer screening programs in Switzerland Kevin Selby, Lausanne |
| 1400 - 1430 Auditorium | How do I perform colorectal cancer screening - and how to follow-up after polypectomy Monika Ferlitsch, Wien, Austria |
| 1430 - 1500 Auditorium | Can artificial intelligence improve colorectal cancer screening? Cesare Hassan, Milano, Italy |
| 1330 - 1500 Theatersaal | IBD and oral presentations IBD/EoE/gastroenterology Gerhard Rogler, Zürich Emanuel Burri, Liestal Sophie Restellini, Meyrin/Genève |
| 1330 - 1400 Theatersaal | Keynote lecture: Pouch complications and treatment options Mark Silverberg, Toronto, Canada |
| 1400 - 1410 Theatersaal | Symptomatic remission and IUS improvements in a multi-national real-world cohort of UC patients treated with Upadacitinib - Results from the IBD-DACH study EUROPE |
| 1410 - 1420 Theatersaal | Efficacy and safety of upadacitinib in patients with moderately to severely active Crohn’s Disease: results from the U-ENDURE long-term extension |
| 1420 - 1430 Theatersaal | Population pharmacokinetic modelling of oral upadacitinib: a real-world prospective observational study |
| 1430 - 1440 Theatersaal | Advanced Therapies, the best combinations in refractory IBD patients. |
| 1440 - 1450 Theatersaal | Mismatch in physician and patient perception of fecal urgency and incontinence in inflammatory bowel disease – the fecal urgency survey |
| 1450 - 1500 Theatersaal | Harnessing Intestinal ILC3s through the Aryl-Hydrocarbon- Receptor Target Gene Cyp2s1 |
| 1330 - 1500 Kongresssaal | Oral presentations hepatology Markus Heim, Basel Andrea De Gottardi, Luzern |
| 1330 - 1400 Kongresssaal | Keynote lecture: Artificial intelligence in liver pathology Julien Calderaro, Paris, France |
| 1400 - 1410 Kongresssaal | Acute-liver-failure-study-group (ALFSG)- and MELD scores
are superior to Clichy and Kings College Criteria in
predicting transplant-free survival. |
| 1410 - 1420 Kongresssaal | Biological and neuro-functional skin analyses identify distinct alterations in patients with cholestatic liver disease-associated pruritus |
| 1420 - 1430 Kongresssaal | Transcriptomic and proteomic profiles of Hepatocellular Carcinoma and non-tumor liver tissue differ in samples obtained by biopsy or resection |
| 1430 - 1440 Kongresssaal | Post-surgical adjuvant benzimidazole therapy in alveolar echinococcosis: is an abbreviated course feasible? |
| 1440 - 1450 Kongresssaal | Paneth Cells as novel regulators of Intestinal Lymphangiogenesis and lipid metabolism in Metabolic dysfunction-Associated Steatotic Liver Disease Michael Frey, Zurich |
| 1450 - 1500 Kongresssaal | The Swiss Hepatocellular Adenoma Registry: SASL Study 45 |
| 1330 - 1500 Saal Brünig | SGVC Session II: State of the art: Endocrine surgery Fariba Abbassi, Zürich Markus Weber, Zürich |
| 1330 - 1352 Saal Brünig | Malignant thyroid neoplasms Reto Kaderli, Bern |
| 1352 - 1414 Saal Brünig | Benign thyroid diseases Thomas Clerici, St. Gallen |
| 1414 - 1436 Saal Brünig | Diseases of the parathyroid gland Diana Vetter, Zürich |
| 1436 - 1458 Saal Brünig | Surgical diseases of the adrenal gland Maurice Matter, Lausanne |
| 1500 - 1530 Exhibition Area | Coffee break |
| 1500 - 1530 Exhibition Area | Poster Walks Gastroenterology and Hepatology |
| 1530 - 1700 Auditorium | SVEP-SGG Session Jungfrau Marathon Endoscopy: What should a nurse and a physician know about these techniques? Part III: Economic and ecological aspects of endoscopy (simultaneous interpreting into German and French) Lukas Degen, Basel Ellen Utzinger, Wallisellen |
| 1530 - 1600 Auditorium | Ecological aspects of endoscopy: Sustainable gastroenterology: Making a real difference Sophie Buyse, Yverdon |
| 1600 - 1630 Auditorium | Economic costs of endoscopy: Are advanced endoscopic procedures properly reimbursed? Stefan Seewald, Zürich |
| 1630 - 1700 Auditorium | Billing in endoscopy: what will change with TARDOC and EFAS? Florian Riniker, Aarau |
| 1530 - 1700 Theatersaal | Endoscopy and oral presentations endoscopy and gastroenterology Jean-Louis Frossard, Genève Gian-Marco Semadeni, St. Gallen Christoph Schlag, Zürich |
| 1530 - 1600 Theatersaal | Keynote lecture: Update on endoscopic therapy of non-variceal upper GI bleeding Alexander Meining, Würzburg, Germany |
| 1600 - 1610 Theatersaal | Next-Generation Sequencing of Pancreas Cyst Fluid: preliminary results from a tertiary centre registry |
| 1610 - 1620 Theatersaal | A Clinical Model Predicts the Development of an Anastomotic Stricture after Minimally Invasive Esophagectomy – The EsoStricture Study Christoph Kümmerli, Basel |
| 1620 - 1630 Theatersaal | Characterization of small intestinal microbiome across compartments and clinical entities: minor impact of bacterial overgrowth? |
| 1630 - 1640 Theatersaal | Beta-Adrenergic Drive Impairs Gut-vascular Barrier (GVB): Mechanism Involved in small intestinal-barrier Dysfunction in Cirrhosis and Acute-on-chronic Liver Failure (ACLF) |
| 1640 - 1650 Theatersaal | Swallowed topical tacrolimus induces clinical and histological remission in a subset of patients with severe lymphocytic esophagitis |
| 1650 - 1700 Theatersaal | Unraveling the Role of GPR35 in Eosinophilic Esophagitis |
| 1530 - 1700 Kongresssaal | "Jungfrau Joch: the TOP of Europe": Top European experts in gastroenterology, endoscopy, and hepatology Markus Heim, Basel Jan Borovicka, St. Gallen Gerhard Rogler, Zürich |
| 1530 - 1555 Kongresssaal | Update on the management of Helicobacter pylori infection Peter Malfertheiner, Magdeburg, Germany |
| 1555 - 1615 Kongresssaal | Integrative medicines: Ready for IBD prime time? Shomron Ben-Horin, Tel Aviv, Israel |
| 1615 - 1635 Kongresssaal | Management of difficult biliary acces in ERCP Horst Neuhaus, Düsseldorf, Germany |
| 1635 - 1700 Kongresssaal | What's new in viral hepatitis Thomas Berg, Leipzig, Germany |
| 1530 - 1700 Saal Brünig | SGVC III: State-of-the-art Parietology Diego De Lorenzi, Grabs Valentine Luzuy-Guarnero, Lausanne |
| 1530 - 1552 Saal Brünig | TAPP, TEP, TIPP, topp? Lea Stoll, Basel |
| 1552 - 1614 Saal Brünig | Open repair of incisional hernia Alend Saadi, Neuchâtel |
| 1614 - 1636 Saal Brünig | Minimally invasive repair of incisional hernia Tobias Haltmeier, Bern |
| 1636 - 1658 Saal Brünig | Complications after hernia repair Andrea Donadini, Lugano |
| 1530 - 1700 Saal Grimsel | Schulung mikrobiologische Tests Frank Bieger, Baden Hygienegruppe SVEP-ASPE, |
| 1715 - 1830 Saal Brünig | General Assembly SGVC |
| 1715 - 1815 Theatersaal | General Assembly SGGSSG |
| 1815 - 1900 Spycher | General Assemly SVEP-ASPE with Apéro |
| 1815 - 1900 Kongresssaal | General Assembly MDL |
| 1815 - 1900 Theatersaal | General Assembly SASL |
| 1815 - 1900 Saal Harder | General Assembly Swiss NGM |
| 1815 - 1900 Auditorium | General Assemly IBDnet |
Friday, 13.9.2024
| 0745 - 0815 Theatersaal | Early Bird Symposium sanofi-aventis: Managing EoE type 2 comanifestations: Tough to swallow? Alain Schoepfer, Lausanne Denis Comte, Lausanne |
| 0830 - 1000 Auditorium | SVEP-SGG Session "Eiger North face": My toughest case in gastroenterology, hepatology and endoscopy (simultaneous interpreting into German and French) Pierre Michetti, Lausanne Jean-Louis Frossard, Genève |
| 0830 - 0855 Auditorium | My toughest case of acute severe ulcerative colitis: Assessment and Management Graham Radford-Smith, Brisbane, Australia |
| 0855 - 0915 Auditorium | Severe fistulizing Crohn's disease Gerhard Rogler, Zürich |
| 0915 - 0935 Auditorium | My worst complication ever Christoph Gubler, Zürich |
| 0935 - 1000 Auditorium | Acute liver failure Nicolas Goossens, Genève |
| 0830 - 1000 Theatersaal | Eosinophilic esophagitis (EoE) and oral presentations EoE / IBD and gastroenterology (sponsored by sanofi-aventis) Alain Schoepfer, Lausanne Luc Biedermann, Zürich |
| 0830 - 0905 Theatersaal | Diagnosis and therapy of EoE Alain Schoepfer, Lausanne |
| 0905 - 0930 Theatersaal | Dupilumab: A novel therapeutic option for EoE: Mode of action, indications and study results Luc Biedermann, Zürich |
| 0930 - 0940 Theatersaal | Real-life effectiveness of topical steroids, PPI and elimination diets in adults with eosinophilic esophagitis Florian Rybinski, Basel |
| 0940 - 0950 Theatersaal | A Novel Transcriptomic Panel Identifies Histologically Active Eosinophilic Esophagitis |
| 0950 - 1000 Theatersaal | Cross-sectional and longitudinal analyses identify non-specific esophagitis as a distinct fibrotic disease entity of the esophagus |
| 0830 - 1000 Kongresssaal | SASL Hot topics in liver disease 2024 Anja Lachenmayer, Bern Annalisa Berzigotti, Bern |
| 0830 - 0855 Kongresssaal | Update on the therapy of MASLD David Semela, St. Gallen |
| 0855 - 0920 Kongresssaal | Hepatitis D therapy Heiner Wedemeyer, Hannover, Germany |
| 0920 - 0940 Kongresssaal | Symptom burden in liver disease Andreas Kremer, Zürich |
| 0940 - 1000 Kongresssaal | Machine perfusion in liver transplantation Philipp Dutkowski, Basel |
| 0830 - 1000 Saal Brünig | SGVC Rapid fire answers to hot topics Markus K. Müller, Frauenfeld Beat Schnüriger, Bern |
| 0830 - 0842 Saal Brünig | The value of pre-op liver function tests before hepatectomy Philipp Kron, Zürich |
| 0842 - 0854 Saal Brünig | Role of AI in HPB surgery Joël L. Lavanchy, Basel |
| 0854 - 0906 Saal Brünig | Surgical indications for benign thyroid disease Roswitha Köberle, Liestal |
| 0906 - 0918 Saal Brünig | Thyroidectomy from medical to lateral dissection - pros and cons Marco Demarchi, Genève |
| 0918 - 0930 Saal Brünig | Robotic hiatal hernia repair - what are the advantages for the surgeon and the patient? Urs Zingg, Schlieren |
| 0930 - 0942 Saal Brünig | OPRA, TNT, what is the gold standard multimodal treatment for rectal cancer? Vaihere Delaune, Genève |
| 0942 - 0954 Saal Brünig | Immunotherapy - a gamechanger in which cancers to date? Intidhar Labidi-Galy, Genève |
| 0830 - 1000 Saal Grimsel | SVEP-ASPE: Wissenswertes Hygiene 2024 DE Rafael Moreno, Bern |
| 0830 - 1000 Saal Harder | ASPE-SVEP: Hygiène: à savoir en 2024 FR Rafael Moreno, Bern |
| 1000 - 1030 Exhibition Area | Coffee break |
| 1030 - 1200 Auditorium | Joint session: Artificial intelligence (simultaneous interpreting into German and French) Stephan Brand, St. Gallen Guido Beldi, Bern Christoph Gubler, Zürich |
| 1030 - 1100 Auditorium | Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis Vlad Ratziu, Paris, France |
| 1100 - 1130 Auditorium | Artificial intelligence in endoscopy Helmut Messmann, Augsburg, Germany |
| 1130 - 1200 Auditorium | Imaging, robotics, deep learning: cybernetic tools for surgical precision Michele Diana, Genève |
| 1030 - 1200 Saal Harder | SVEP-ASPE: Meet the expert 2024: Polypektomie / polypéctomie (sponsored by Desomedical, Duomed, Mositech, Olympus) Patrick Aepli, Luzern Stefan Seewald, Zürich Sandro Brunner, Luzern Anna Zakowicz, Zürich Bozena Starzyk, Zürich Sylke Luchsinger, Zürich Ines Friebe, Aarau Martin Müller, Chur |
| 1030 - 1200 Saal Grimsel | SVEP-ASPE: Meet the expert 2024: Polypektomie / polypéctomie (sponsored by Desomedical, Duomed, Mositech, Olympus) Patrick Aepli, Luzern Stefan Seewald, Zürich Sandro Brunner, Luzern Anna Zakowicz, Zürich Bozena Starzyk, Zürich Sylke Luchsinger, Zürich Ines Friebe, Aarau Martin Müller, Chur |
| 1200 - 1330 Exhibition Area | Lunch Break |
| 1215 - 1245 Kongresssaal | Lunch Symposium abbvie: IBD treatment has advanced: Exploring two new options for your patients Pierre Michetti, Lausanne Gerhard Rogler, Zürich |
| 1215 - 1245 Theatersaal | Lunch Symposium Schwabe Pharma: Disorders of Gut-Brain Interaction - what’s new? Daniel Pohl, Zürich Ioannis Linas, Bern Giovanni Barbara, Bologna |
| 1250 - 1320 Theatersaal | Lunch Symposium Takeda Pharma: The future of personalized medicine in IBD starts with you! Sophie Restellini, Meyrin/Genève Nurulamin Noor, Cambridge, United Kingdom |
| 1250 - 1320 Kongresssaal | Lunch Symposium Eli Lilly (Suisse): First-in-class IL-23p19 Inhibitor Omvoh® (Mirikizumab): Long-Term Efficacy and Safety in Ulcerative Colitis - Swiss Patient Experience Gerhard Rogler, Zürich Pascal Juillerat, Bern, Fribourg |
| 1330 - 1500 Auditorium | SVEP-SGG Session Jungfrau Marathon Endoscopy: What should a nurse an a physician know about these techniques? Part IV: Advanced endoscopic techniques (simultaneous interpreting into German and French) Christoph Schlag, Zürich Frans Olivier The, Zürich |
| 1330 - 1400 Auditorium | Esophageal stenting Gian-Marco Semadeni, St. Gallen |
| 1400 - 1430 Auditorium | Technical aspects of ESD in the esophagus and stomach Oliver Pech, Regensburg, Germany |
| 1430 - 1500 Auditorium | Cholangioscopy: when and how to perform? Horst Neuhaus, Düsseldorf, Germany |
| 1330 - 1500 Theatersaal | A quick "Tour de Suisse" in gastroenterology and hepatology: Tips and tricks for my daily clinical practice Lukas Degen, Basel Kaspar Truninger, Zürich Annalisa Berzigotti, Bern |
| 1330 - 1340 Theatersaal | Do's and Dont's in medical therapy of IBD in pregnancy Sophie Restellini, Meyrin/Genève |
| 1340 - 1350 Theatersaal | What a gastroenterologist should know about hepatitis E Darius Moradpour, Lausanne |
| 1350 - 1400 Theatersaal | How do I stop variceal bleeding? Reiner Wiest, Bern |
| 1400 - 1410 Theatersaal | How do I treat IBS? Daniel Pohl, Zürich |
| 1410 - 1420 Theatersaal | What should I know about JAK inhibitor therapy in IBD? Emanuel Burri, Liestal |
| 1420 - 1430 Theatersaal | How do I treat fatty liver disease in 2024? David Semela, St. Gallen |
| 1430 - 1440 Theatersaal | How should I treat portal hypertension Andrea De Gottardi, Luzern |
| 1440 - 1450 Theatersaal | How do I treat constipation Daniele Riva, Lugano |
| 1330 - 1500 Kongresssaal | CASINO Interlaken (Clinics And Science IN One: Clinically relevant science: Highest rated abstracts in gastroenterology and hepatology) Daniel Pohl, Zürich Montserrat Fraga, Lausanne Andrew Macpherson, Bern |
| 1330 - 1340 Kongresssaal | Identifying Putative Genomic Biomarkers For Risk Stratification in Barrett’s Esophagus Patients With Normal Histological Features Blanca Montcusí, Barcelona, Geneva |
| 1340 - 1350 Kongresssaal | Genomic Markers For Enhanced Risk Stratification in Barrett’s Esophagus Patients With Low Grade Dysplasia Roger Scherer, Luzern |
| 1350 - 1400 Kongresssaal | Systemic and mucosal immune responses against the SARS-CoV-2 XBB.1.5, EG.5.1, and BA.2.86 lineages induced by monovalent XBB.1.5-adapted COVID-19 mRNA vaccines in patients with inflammatory bowel disease |
| 1400 - 1410 Kongresssaal | A Role for Transferrin Receptor 1 in Hepatitis E Virus Particle Production |
| 1410 - 1420 Kongresssaal | The role of protein tyrosine phosphatase non-receptor type 2 in regulating hepatic cytotoxic T cells and as a therapeutic target in metabolic dysfunction-associated steatohepatitis |
| 1420 - 1430 Kongresssaal | Rising Incidence and Severity of Hypersensitivity Reactions Related to the Contrast Agent SonoVue® Applied in Contrast-Enhanced Ultrasound (CEUS) |
| 1430 - 1500 Kongresssaal | Advances in IBS pathophysiology research and relationship with modern treatment of IBS Magnus Simrén, Gothenburg, Sweden |
| 1330 - 1500 Saal Brünig | SGVC Largiadèr Session Antonio Nocito, Baden Guido Beldi, Bern |
| 1330 - 1340 Saal Brünig | Milestones in Surgical Complication Reporting.
20 Years of Clavien-Dindo Classfication &
10 Years of Comprehensive Complication Index (CCI®) Livia Kammerlander, St. Gallen |
| 1340 - 1350 Saal Brünig | Long-term outcomes after hepatectomy for alveolar echinococcosis in immunocompromised patients |
| 1350 - 1400 Saal Brünig | Antegrade balloon dilatation of the duodenal papilla during laparoscopic cholecystectomy versus endoscopic retrograde cholangiography in patients with acute choledocholithiasis: a case control matched study |
| 1400 - 1410 Saal Brünig | Impact of Charlson Comorbidity Index (CCI) on Enhanced Recovery after Surgery (ERAS) in colorectal surgery |
| 1410 - 1420 Saal Brünig | Towards a Standardization of Learning Curve Assessment in Minimally Invasive Liver Surgery |
| 1420 - 1430 Saal Brünig | Five decades of Pancreas Transplantation at the University Hospital of Zurich – a story of continuous improvement and success |
| 1430 - 1440 Saal Brünig | Long-term results after transoral outlet reduction (TORe) of the gastrojejunal anastomosis for secondary weight regain and dumping syndrome after Roux-en-Y gastric bypass |
| 1440 - 1450 Saal Brünig | The Impact Of Clinical Parameters And Neoadjuvant Treatment On The Tumor Microenvironment Of Esophageal Cancer |
| 1450 - 1500 Saal Brünig | The Spermidine Pathway Identifies Patients at Risk for Tumor Recurrence after Colorectal Cancer Surgery |
| 1330 - 1500 Saal Grimsel | SVEP-ASPE: Meet the expert 2024: ERCP (sponsored by Boston Scientific, Cook Medical, Desomedical, Olympus) Christoph Gubler, Zürich Remus Frei, St. Gallen Camille Dutronc, Zürich Karin Steinmetz, St. Gallen Ines Friebe, Aarau Martin Müller, Chur |
| 1330 - 1830 Saal Susten | Scientific meeting: Swiss Society for Sacral Neuromodulation (SSSNM) Lukas Marti, St. Gallen |
| 1330 - 1500 Saal Harder | SVEP-ASPE: Meet the expert 2024: ERCP (sponsored by Boston Scientific, Cook Medical, Desomedical, Olympus) Christoph Gubler, Zürich Remus Frei, St. Gallen Camille Dutronc, Zürich Karin Steinmetz, St. Gallen Ines Friebe, Aarau Martin Müller, Chur |
| 1330 - 1415 Saal Susten | Physiotherapists, what can they do? Pelvic floor exercises and more: in faecal as well as urinary voiding and leaking problems Karin Uffer, St. Gallen |
| 1415 - 1500 Saal Susten | Sacral Neuromodulation: Pros and cons of the currently available devices |
| 1500 - 1530 Saal Susten | Coffee break SSSNM |
| 1530 - 1730 Saal Susten | Morbidity Conference: presentation and discussion of interesting cases Cécile Tawadros, Rennaz |
| 1745 - 1830 Saal Susten | General Assembly SSSNM Lukas Marti, St. Gallen |
| 1500 - 1530 Exhibition Area | Coffee break |
| 1530 - 1700 Auditorium | SVEP-SGG Session: A quick "Video Tour de Suisse" in endoscopy: Tips and tricks for my daily endoscopic practice (simultaneous interpreting into German and French) Christoph Gubler, Zürich Remus Frei, St. Gallen |
| 1530 - 1540 Auditorium | Interventional EUS Jean-Louis Frossard, Genève |
| 1540 - 1550 Auditorium | Endoscopic dilatation in EoE Alain Schoepfer, Lausanne |
| 1550 - 1600 Auditorium | EUS-HGS in malignant obstruction Reiner Wiest, Bern |
| 1600 - 1610 Auditorium | Endoscopic dilatation of stenosis in Crohn's disease Emanuel Burri, Liestal |
| 1610 - 1620 Auditorium | Endoscopic management of obstructive dilemmas in upper GI-disease Frans Olivier The, Zürich |
| 1620 - 1630 Auditorium | Short-type single balloon enteroscope for ERP in pancreaticojejunostomy Remus Frei, St. Gallen |
| 1630 - 1640 Auditorium | Endoscopic suturing: who, when & how Patrick Aepli, Luzern |
| 1640 - 1650 Auditorium | Interesting endoscopic case Daniele Riva, Lugano |
| 1530 - 1700 Kongresssaal | Young gastroenterologists: Parachute Interlaken. My parachute for the exam and clinical practice Henriette Heinrich, Basel |
| 1530 - 1550 Kongresssaal | The European Board of Gastroenterology Exam - Slay the prep! Marius König, St. Gallen |
| 1550 - 1610 Kongresssaal | Challenges in the management of a private practice Daniele Riva, Lugano |
| 1610 - 1630 Kongresssaal | The gateway into academia – how shall I start? Sena Blümel, Zürich |
| 1630 - 1700 Kongresssaal | Don’t hesitate - communicate: What surgeons and gastroenterologist need from each other Henriette Heinrich, Basel Styliani Mantziari, Lausanne |
| 1530 - 1700 Saal Brünig | SGVC surgey oral presentations Andrea Donadini, Lugano Beat Schnüriger, Bern |
| 1530 - 1540 Saal Brünig | Anastomotic Leak Microbiome Pattern is Associated with Tumor Recurrence in Colorectal Cancer Patients |
| 1540 - 1550 Saal Brünig | Postpancreatectomy hyperamylasemia is associated with postoperative pancreatic fistula but not overall morbidity or mortality Sonja K Malcher, Baden |
| 1550 - 1600 Saal Brünig | Implementing Semantic Search for Cohort Selection Using Procedure-Based CHOP Codes |
| 1600 - 1610 Saal Brünig | Contact x-ray radiotherapy for organ preservation in rectal cancer |
| 1610 - 1620 Saal Brünig | Frailty Assessment for Risk Stratification in Pancreatic Sur- gery? Results of a Single-Center Cohort Study |
| 1620 - 1630 Saal Brünig | Prediction of Postsurgical Infection by Explainable AI and Strategic Data Imputation |
| 1630 - 1640 Saal Brünig | Intraperitoneal Onlay Mesh Plasty (IPOM) for primary abdominal wall herniation- Incidence of Ileus and Adhesions |
| 1640 - 1650 Saal Brünig | Tailgutcyst: a rare but not uncommon disease |
| 1650 - 1700 Saal Brünig | Evidence Map of Appendicitis – a living systematic review with meta-analyses |